• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Titan Pharmaceuticals Inc

+ Add to Watchlist

TN7:GR

0.570 EUR 0.0000.00%

As of 02:11:05 ET on 07/28/2014.

Snapshot for Titan Pharmaceuticals Inc (TN7)

Open: 0.570 Day's Range: 0.570 - 0.570 Volume: 0
Previous Close: 0.570 52wk Range: 0.370 - 0.800 1-Yr Rtn: +32.56%

Stock Chart for TN7

No chart data available.
  • TN7:GR 0.570
  • 1D
  • 1M
  • 1Y
0.570
Interactive TN7 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TN7

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 50.76
Shares Outstanding (M) 89.05
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TN7

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TN7

Titan Pharmaceuticals, Inc. is a biopharmaceutical company that develops proprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. The company is also developing gene therapy and drug delivery technologies.

Marc RubinChairmanSunil BhonslePresident
More Company Profile & Key Executives for TN7

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil